Opinionated Science

Episode 30: Psychedelics: A Trip Through Psilocybin and MDMA Research

June 21, 2021

On this week’s Opinionated Science, the team take a look at the growing potential of psychedelic medicine.

Hundreds of new clinical trials, exciting new synthetic psychedelics and a universal acceptance that current mental health treatments are not meeting patients’ needs have pushed the mind-altering potential of psychedelics into the medical mainstream.

In this episode, Technology Networks Senior Science Writer Ruairi J Mackenzie takes a deep dive into four leading psychedelic compounds: psilocybin, MDMA, ketamine and DMT.

Read more from this podcast:

Why Does Ketamine Fight Depression? Finding Answers at BNA 2019

Mirror’s Image: Could a Simple Flip Produce a More Effective Ketamine-Based Antidepressant?

The Neuroscience of Psychedelic Drugs: Your Brain on Psilocybin With Frederick Streeter Barrett

Podbean App

Play this podcast on Podbean App